Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis.
about
Suppression of La antigen exerts potential antiviral effects against hepatitis A virusInterplay between influenza A virus and host factors: targets for antiviral intervention.Selective JAK inhibitors in development for rheumatoid arthritis.Influenza virus-host interactome screen as a platform for antiviral drug development
P2860
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Clinical utility of the oral J ...... tment of rheumatoid arthritis.
@en
type
label
Clinical utility of the oral J ...... tment of rheumatoid arthritis.
@en
prefLabel
Clinical utility of the oral J ...... tment of rheumatoid arthritis.
@en
P2860
P356
P1476
Clinical utility of the oral J ...... tment of rheumatoid arthritis.
@en
P2093
Marianna Meroni
Maurizio Cutolo
P2860
P304
P356
10.2147/JIR.S35901
P407
P577
2013-11-15T00:00:00Z